Your browser is no longer supported. Please, upgrade your browser.
ANIP ANI Pharmaceuticals, Inc. daily Stock Chart
ANIP [NASD]
ANI Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.14 Insider Own4.20% Shs Outstand11.90M Perf Week-1.96%
Market Cap384.83M Forward P/E6.77 EPS next Y4.59 Insider Trans0.97% Shs Float9.47M Perf Month-26.05%
Income-1.50M PEG- EPS next Q1.00 Inst Own86.70% Short Float6.47% Perf Quarter-35.31%
Sales203.40M P/S1.89 EPS this Y-61.80% Inst Trans-1.61% Short Ratio5.21 Perf Half Y-47.07%
Book/sh16.90 P/B1.84 EPS next Y11.37% ROA-0.30% Target Price- Perf Year-54.17%
Cash/sh1.65 P/C18.86 EPS next 5Y2.20% ROE-0.70% 52W Range28.28 - 86.96 Perf YTD-49.64%
Dividend- P/FCF14.41 EPS past 5Y-28.10% ROI4.80% 52W High-64.28% Beta1.53
Dividend %- Quick Ratio1.30 Sales past 5Y29.80% Gross Margin65.50% 52W Low9.83% ATR2.30
Employees338 Current Ratio2.00 Sales Q/Q-5.90% Oper. Margin2.10% RSI (14)36.66 Volatility4.23% 6.76%
OptionableYes Debt/Eq0.99 EPS Q/Q- Profit Margin-0.70% Rel Volume1.51 Prev Close31.79
ShortableYes LT Debt/Eq0.93 EarningsMay 07 BMO Payout- Avg Volume117.66K Price31.06
Recom1.70 SMA20-7.94% SMA50-19.64% SMA200-45.64% Volume177,490 Change-2.30%
May-07-20Downgrade Cantor Fitzgerald Overweight → Neutral
Sep-12-19Initiated Guggenheim Buy
May-10-19Downgrade Raymond James Strong Buy → Outperform $73 → $82
Oct-16-17Reiterated Canaccord Genuity Buy $60 → $66
Jul-31-17Initiated Canaccord Genuity Buy $60
Feb-22-17Downgrade ROTH Capital Buy → Neutral
Jun-23-16Initiated Raymond James Strong Buy $68
May-24-16Downgrade Standpoint Research Buy → Hold
Nov-13-15Initiated Standpoint Research Buy $54
Sep-28-15Upgrade ROTH Capital Neutral → Buy $67 → $60
Aug-05-15Reiterated Oppenheimer Outperform $74 → $65
Aug-04-15Reiterated ROTH Capital Neutral $70 → $67
Jul-31-15Reiterated Oppenheimer Outperform $72 → $74
Jul-15-15Reiterated ROTH Capital Neutral $60 → $70
Jun-23-15Reiterated Oppenheimer Outperform $61 → $67
May-18-15Reiterated ROTH Capital Neutral $78 → $60
May-06-15Reiterated Oppenheimer Outperform $69 → $61
Apr-10-15Downgrade ROTH Capital Buy → Neutral $78
Feb-26-15Reiterated ROTH Capital Buy $65 → $78
Feb-18-15Reiterated Oppenheimer Outperform $58 → $69
May-09-20 08:21AM  Earnings Release: Here's Why Analysts Cut Their ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Price Target To US$45.67 Simply Wall St.
May-08-20 06:30PM  ANI Pharmaceuticals Inc (ANIP) Q1 2020 Earnings Call Transcript Motley Fool
07:12AM  Edited Transcript of ANIP earnings conference call or presentation 7-May-20 2:30pm GMT Thomson Reuters StreetEvents
May-07-20 09:55AM  ANI Pharmaceuticals (ANIP) Q1 Earnings and Revenues Surpass Estimates Zacks -7.85%
08:30AM  ANI Pharmaceuticals Reports First Quarter 2020 Results and Appoints Interim CEO PR Newswire
May-01-20 11:50AM  Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now? Zacks
Apr-30-20 08:30AM  ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2020 Financial Results PR Newswire
Apr-29-20 08:30AM  ANI Receives Refusal to File Letter from FDA for Cortrophin® Gel PR Newswire -8.50%
Apr-24-20 06:45AM  The ANI Pharmaceuticals (NASDAQ:ANIP) Share Price Is Down 40% So Some Shareholders Are Getting Worried Simply Wall St.
Apr-14-20 08:30AM  ANI Announces Upcoming Departure of CEO PR Newswire -8.98%
Apr-13-20 08:30AM  ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL PR Newswire +6.12%
Apr-02-20 08:30AM  ANI Pharmaceuticals Announces Launch of Omega-3-Acid Ethyl Esters Capsules USP PR Newswire
Mar-26-20 08:30AM  ANI Announces Launch of Polyethylene Glycol 3350, 17g/Packet PR Newswire
Mar-24-20 08:30AM  ANI Pharmaceuticals Announces the Filing of a Prior Approval Supplement for Purified Cortrophin® Gel 80 U/mL PR Newswire +24.22%
Mar-11-20 03:37PM  Edited Transcript of ANIP earnings conference call or presentation 27-Feb-20 3:30pm GMT Thomson Reuters StreetEvents
Mar-10-20 06:40AM  A Sliding Share Price Has Us Looking At ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) P/E Ratio Simply Wall St.
Mar-05-20 07:17AM  New Strong Sell Stocks for March 5th Zacks -7.34%
Mar-02-20 08:30AM  ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules PR Newswire -7.81%
Feb-29-20 07:35AM  Earnings Miss: ANI Pharmaceuticals, Inc. Missed EPS By 53% And Analysts Are Revising Their Forecasts Simply Wall St.
Feb-27-20 10:05AM  ANI Pharmaceuticals (ANIP) Q4 Earnings and Revenues Lag Estimates Zacks -18.68%
08:30AM  ANI Pharmaceuticals Reports Full Year and Fourth Quarter 2019 Results, Provides 2020 Guidance and Remains on Track to Submit Cortrophin® Gel sNDA to FDA in March 2020 PR Newswire
Feb-24-20 12:45PM  3 Fast-Growing CapEx Stocks GuruFocus.com
Feb-21-20 05:25AM  Read This Before Judging ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) ROE Simply Wall St.
Feb-20-20 08:30AM  ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and Year-to-Date 2019 Financial Results PR Newswire
Feb-19-20 12:31PM  Earnings Preview: ANI Pharmaceuticals (ANIP) Q4 Earnings Expected to Decline Zacks
Feb-12-20 08:30AM  ANI Announces Launch of Sulfamethoxazole and Trimethoprim Oral Suspension USP 200 mg/40 mg per 5 mL PR Newswire
Jan-24-20 08:30AM  ANI Announces Launch of Tolterodine Extended-Release Capsules PR Newswire
Jan-16-20 08:30AM  ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP PR Newswire
05:39AM  Is ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) CEO Pay Justified? Simply Wall St.
Jan-14-20 08:30AM  ANI Announces Launch of Paliperidone Extended-Release Tablets PR Newswire
Jan-09-20 08:30AM  ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd. PR Newswire
Dec-19-19 10:09AM  4 Drug/Biotech Outperformers That May Lose Steam in 2020 Zacks
Dec-18-19 08:30AM  ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL PR Newswire
Dec-11-19 01:55PM  Is ANI Pharmaceuticals Inc (ANIP) Going To Burn These Hedge Funds ? Insider Monkey
05:06AM  Before You Buy ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), Consider Its Volatility Simply Wall St.
Dec-04-19 09:21AM  New Strong Sell Stocks for December 4th Zacks
07:45AM  Moving Average Crossover Alert: ANI Pharmaceuticals Zacks
Nov-26-19 08:30AM  ANI Pharmaceuticals to Present at Evercore ISI 2nd Annual HealthCONx Conference PR Newswire
Nov-22-19 05:19PM  Edited Transcript of ANIP earnings conference call or presentation 6-Nov-19 3:30pm GMT Thomson Reuters StreetEvents
Nov-11-19 06:25AM  Estimating The Intrinsic Value Of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Simply Wall St.
Nov-06-19 09:55AM  ANI Pharmaceuticals (ANIP) Lags Q3 Earnings and Revenue Estimates Zacks -23.75%
08:30AM  ANI Pharmaceuticals Reports Third Quarter Results PR Newswire
08:21AM  The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings Benzinga
Oct-31-19 08:30AM  ANI Announces Plans to Launch Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml) for Ventricular Arrhythmias PR Newswire
Oct-30-19 08:30AM  ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2019 Financial Results PR Newswire
Oct-29-19 10:33AM  ANI Pharmaceuticals (ANIP) to Report Q3 Results: Wall Street Expects Earnings Growth Zacks
08:30AM  ANI Pharmaceuticals announces the launch of ANI Global Source, its contract development and manufacturing business PR Newswire
Oct-28-19 04:14PM  Here is What Hedge Funds Think About ANI Pharmaceuticals Inc (ANIP) Insider Monkey
Oct-12-19 08:26AM  Does ANI Pharmaceuticals (NASDAQ:ANIP) Deserve A Spot On Your Watchlist? Simply Wall St.
Oct-11-19 12:18PM  Zacks.com featured highlights include: Assurant, Opera, ANI, eXp and Avista Zacks
Oct-10-19 10:37AM  Zacks.com featured highlights include: Assurant, Opera, ANI, eXp and Avista Zacks
Oct-09-19 09:09AM  5 Stocks to Consider as New Analysts Initiate Coverage Zacks
Oct-03-19 08:30AM  ANI Announces Positive Clinical Results from Cortrophin® Gel Cortisol Response Study PR Newswire
Oct-02-19 08:30AM  ANI Pharmaceuticals Announces Launch of Aspirin and Extended Release Dipyridamole Capsules, 25mg/200mg PR Newswire
Sep-29-19 11:39AM  Hedge Fund Mangrove Partners Top Stock Picks Insider Monkey
Sep-12-19 06:57AM  ANI Pharmaceuticals (NASDAQ:ANIP) Takes On Some Risk With Its Use Of Debt Simply Wall St.
Sep-11-19 08:30AM  ANI Pharmaceuticals Announces Launch of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL PR Newswire
Sep-05-19 06:43PM  Edited Transcript of ANIP earnings conference call or presentation 7-Aug-19 2:30pm GMT Thomson Reuters StreetEvents
Aug-13-19 08:08AM  ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Delivered A Weaker ROE Than Its Industry Simply Wall St.
Aug-07-19 01:23PM  ANI Pharmaceuticals Inc (ANIP) Q2 2019 Earnings Call Transcript Motley Fool -12.04%
09:45AM  ANI Pharmaceuticals (ANIP) Q2 Earnings Surpass Estimates Zacks
08:30AM  ANI Pharmaceuticals Reports Second Quarter Results PR Newswire
Jul-31-19 08:30AM  ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2019 Financial Results PR Newswire
Jul-30-19 10:38AM  ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release Zacks
Jul-09-19 02:38PM  How Much is ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) CEO Getting Paid? Simply Wall St.
Jun-27-19 04:11PM  Hedge Funds Piled Into This Stock Right Before Its Double Digit Gains Insider Monkey
Jun-25-19 08:30AM  ANI Pharmaceuticals Announces Launch of Ranitidine Capsules PR Newswire
Jun-20-19 10:30AM  ANI Pharmaceuticals Announces Approval of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5ml PR Newswire
Jun-18-19 08:00AM  ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc. PR Newswire
Jun-12-19 08:30AM  ANI Pharmaceuticals to Present at Raymond James Life Sciences and MedTech Conference PR Newswire
May-31-19 12:38PM  Is ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Trading At A 48% Discount? Simply Wall St.
May-16-19 09:00AM  What Makes ANI (ANIP) a New Buy Stock Zacks
May-12-19 11:52AM  Edited Transcript of ANIP earnings conference call or presentation 9-May-19 2:30pm GMT Thomson Reuters StreetEvents
May-10-19 10:23AM  ANI Pharmaceuticals Inc (ANIP) Q1 2019 Earnings Call Transcript Motley Fool
May-09-19 01:14PM  Did Hedge Funds Drop The Ball On ANI Pharmaceuticals Inc (ANIP) ? Insider Monkey
08:39AM  ANI: 1Q Earnings Snapshot Associated Press
08:30AM  ANI Pharmaceuticals Reports First Quarter 2019 Results and Reaffirms Guidance PR Newswire
May-02-19 08:30AM  ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2019 Financial Results PR Newswire
May-01-19 05:45PM  ANI Pharmaceuticals (ANIP) Dips More Than Broader Markets: What You Should Know Zacks
Apr-30-19 09:00AM  The Zacks Analyst Blog Highlights: Bed Bath & Beyond, ANI, DXP, Foot Locker and ACI Zacks
08:32AM  What's in Store for ANI Pharmaceuticals (ANIP) Q1 Earnings? Zacks
Apr-29-19 08:05AM  American Economy Hits the Gas: 5 Top Gainers Zacks
Apr-27-19 09:04AM  If You Had Bought ANI Pharmaceuticals (NASDAQ:ANIP) Shares Five Years Ago You'd Have Made 115% Simply Wall St.
Apr-26-19 11:11AM  Medicines Company (MDCO) Q1 Loss Narrows, Inclisiran in Focus Zacks
Apr-25-19 05:45PM  ANI Pharmaceuticals (ANIP) Dips More Than Broader Markets: What You Should Know Zacks
09:31AM  Alexion (ALXN) Q1 Earnings Beat Estimates, Guidance Raised Zacks
Apr-23-19 09:34AM  Zacks.com featured expert Kevin Matras highlights: Advanced Emissions Solutions, Verint Systems, Great Lakes Dredge & Dock, ANI Pharmaceuticals and ACI Worldwide Zacks
Apr-22-19 09:12AM  5 Stocks With Recent Price Strength to Enhance Your Returns Zacks
Apr-18-19 05:50PM  ANI Pharmaceuticals (ANIP) Stock Sinks As Market Gains: What You Should Know Zacks
Apr-17-19 08:14AM  Ultragenyx's (RARE) UX007 Gets Fast Track Status by FDA Zacks
Apr-16-19 10:54AM  QIAGEN Drives Molecular Diagnostics Suite With New Test Kit Zacks
Apr-15-19 09:30AM  Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year? Zacks
08:45AM  3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP) Zacks
08:30AM  ANI Pharmaceuticals Expands Injectable Portfolio with Distribution Agreement for FDA Approved Injectable Product PR Newswire
Apr-12-19 05:45PM  ANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should Know Zacks
09:46AM  5 Stocks With Increasing Cash Flows to Scoop Up Big Gains Zacks
Apr-11-19 10:43AM  Zacks.com featured expert Kevin Matras highlights: Herc, ANI Pharmaceuticals, Kamada, SP Plus and SkyWest Zacks
09:34AM  BioDelivery (BDSI) Buys US Rights to Pain Drug for $30M Zacks
Apr-10-19 09:30AM  Tap These 6 Stocks That Flaunt Sizeable Net Profit Margin Zacks
Apr-09-19 11:24AM  PhaseBio Stock Up on Breakthrough Therapy Status for PB2452 Zacks
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncolytics (anti-cancers), hormones and steroids, and other formulations. The company offers pharmaceuticals for the treatment of breast cancer, hypertension, ventricular arrhythmias, stage D2 metastatic carcinoma of the prostate, depression, diarrhea, infections, vasomotor symptoms of menopause, pain caused by osteoarthritis and rheumatoid arthritis, epilepsy, arrhythmia, obsessive-compulsive disorder and social anxiety disorder, ulcerative colitis, salt and fluid retention, manic episodes of bipolar disorder, ulcerative colitis, proctosigmoiditis, ocular conditions, metastatic prostate cancer, arrhythmia, migraine headache, and enterocolitis caused by staphylococcus aureus. It also provides aspirin and extended-release dipyridamole; Cholestyramine, an adjunctive therapy to diet for the reduction of elevated serum cholesterol; Ezetimibe-Simvastatin to lower high cholesterol and triglyceride levels; Fenofibrate, a peroxisome proliferator receptor alpha activator; Hydrocortisone rectal cream for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses; Morphine Sulfate, an oral solution for acute and chronic pain management; Nimodipine to enhance neurological outcomes; and Terbutaline Sulfate for the prevention and reversal of bronchospasm. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HAUGHEY THOMASDirectorMar 04Buy45.053,000135,15011,291Mar 05 06:01 PM
HAUGHEY THOMASDirectorMar 03Buy45.182,00090,3608,291Mar 05 06:01 PM
MERIDIAN VENTURE PARTNERS II L10% OwnerAug 20Sale68.185,512375,8082,219,259Aug 21 06:11 PM
MERIDIAN VENTURE PARTNERS II L10% OwnerAug 19Sale68.302,067141,1762,224,771Aug 21 06:11 PM
MERIDIAN VENTURE PARTNERS II L10% OwnerAug 16Sale68.0926,3491,794,1032,226,838Aug 16 05:38 PM
MERIDIAN VENTURE PARTNERS II L10% OwnerAug 15Sale69.349,315645,9022,253,187Aug 16 05:38 PM
MERIDIAN VENTURE PARTNERS II L10% OwnerAug 14Sale69.8926,3601,842,3002,262,502Aug 16 05:38 PM
MERIDIAN VENTURE PARTNERS II L10% OwnerAug 13Sale71.7720,8211,494,3232,288,862Aug 13 06:07 PM
MERIDIAN VENTURE PARTNERS II L10% OwnerAug 12Sale71.4521,0161,501,5932,309,683Aug 13 06:07 PM
MERIDIAN VENTURE PARTNERS II L10% OwnerAug 09Sale71.7019,8601,423,9622,330,699Aug 13 06:07 PM